Trial Profile
Phase I/II Trial of Venetoclax in Combination With R-ICE (V+RICE) Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 23 Sep 2022
Price :
$35
*
At a glance
- Drugs Venetoclax (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 19 Sep 2022 Planned End Date changed from 1 Oct 2022 to 12 Aug 2023.
- 04 Apr 2022 Status changed from recruiting to active, no longer recruiting.
- 26 Jan 2022 Planned End Date changed from 1 Oct 2021 to 1 Oct 2022.